VANCOUVER, British Columbia, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. (“Digicann” or the “Company”) (CSE: DCNN) (OTCPK: AGFAD), a company focused on the cannabis industry, announces that it recently signed and closed the sale of the shares of AgraFlora Europe GmbH (the “AgraFlora Europe”) to an arm’s length third party for gross cash proceeds of €500,000 (the “Transaction”).

温哥华，不列颠哥伦比亚省，2023年10月23日（GLOBE NEWSWIRE）-Digicann Ventures Ltd.（“Digicann”或“Company”）（CSE:DCNN）（OTCPK:AGFAD），一家专注于大麻行业的公司，宣布其最近签署并关闭了将AgraFlora Europe GmbH（“AgraFlora Europe”）的股份出售给公司长度的第三方，现金收益总额为500000欧元（“交易”）。

AgraFlora Europe was set up to be a commercial platform for the import, storage and wholesale distribution of cannabis products and ancillary products for medicinal purposes. Digicann was the sole shareholder of AgraFlora Europe, a German limited liability company that held: 100% of the shares in Farmako GmbH, a company having its registered office located in Frankfurt, Germany ('Farmako');100% of the shares in Farmako Genetics GmbH, a company having its registered office located in Frankfurt, Germany; and100% of the shares in The Good Company Luxembourg SARL, a company having its registered office located in Luxembourg.

AgraFlora Europe成立了一个商业平台，用于医药用途的大麻产品和辅助产品的进口，储存和批发分销。Digicann是德国有限责任公司AgraFlora Europe的唯一股东，该公司持有Farmako GmbH 100%的股份，该公司的注册办事处位于德国法兰克福（'Farmako'）；Farmako Genetics GmbH 100%的股份，该公司的注册办事处位于德国法兰克福；卢森堡SARL良好公司100%的股份，该公司的注册办事处位于卢森堡。

Farmako itself held: 100% of the shares in Farmako Limited, a company having its registered office in Croydon UK; and100% of the shares in Farmako ApS, a company having its registered office in Copenhagen, Denmark. AgraFlora Europe served as a holding company and undertook no operative business activities.

Farmako本身持有：Farmako Limited 100%的股份，Farmako Limited是一家在英国Croydon注册办事处的公司；以及在丹麦哥本哈根注册的公司Farmako ApS的100%股份。AgraFlora Europe是一家控股公司，没有开展任何业务活动。

Farmako and Farmako Limited held various permits and licenses and owned intellectual property in connection with their business activities. At the time of the Transaction, Farmako Genetics, The Good Company and Farmako Denmark carried on no active business operations. This Transaction is governed exclusively by the laws of Germany subject to the exclusion of German conflicts of laws rules (IPR).

Farmako和Farmako Limited持有与其业务活动相关的各种许可证和许可证以及拥有的知识产权。在交易时，Farmako Genetics，Good Company和Farmako Denmark没有进行任何积极的业务运营。本交易完全受德国法律管辖，但不受德国法律规则冲突（IPR）的约束。

The Managing Directors of the applicable companies within the AgraF.

AgraF内适用公司的总经理。